Cencora (COR) Projected to Release Quarterly Earnings on Wednesday

Cencora (NYSE:COR) will likely be issuing its Q3 2026 results before the market opens on Wednesday, August 5th. Analysts expect the company to post earnings of $4.35 per share and revenue of $84.3145 billion for the quarter. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. Individuals may visit the the company’s upcoming Q3 2026 earning report for the latest details on the call scheduled for Wednesday, August 5, 2026 at 8:30 AM ET.

Cencora (NYSE:COR) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $4.75 earnings per share for the quarter, missing the consensus estimate of $4.82 by ($0.07). Cencora had a net margin of 0.78% and a return on equity of 135.20%. The firm had revenue of $78.36 billion during the quarter, compared to analyst estimates of $81.09 billion. During the same period in the previous year, the company posted $4.42 earnings per share. Cencora’s revenue was up 3.9% compared to the same quarter last year. On average, analysts expect Cencora to post $18 EPS for the current fiscal year and $20 EPS for the next fiscal year.

Cencora Stock Up 0.3%

COR stock opened at $312.40 on Monday. The company has a fifty day moving average price of $289.36 and a 200 day moving average price of $315.41. Cencora has a 12 month low of $244.82 and a 12 month high of $377.54. The company has a debt-to-equity ratio of 3.40, a current ratio of 0.95 and a quick ratio of 0.59. The company has a market cap of $60.78 billion, a price-to-earnings ratio of 23.96, a price-to-earnings-growth ratio of 1.73 and a beta of 0.57.

Cencora announced that its board has authorized a share repurchase program on Thursday, May 21st that authorizes the company to buyback $2.00 billion in shares. This buyback authorization authorizes the company to purchase up to 3.9% of its shares through open market purchases. Shares buyback programs are generally a sign that the company’s management believes its shares are undervalued.

Cencora Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, June 1st. Shareholders of record on Friday, May 15th were given a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend was Friday, May 15th. Cencora’s dividend payout ratio (DPR) is presently 18.40%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on COR shares. William Blair started coverage on Cencora in a report on Tuesday, April 28th. They set a “market perform” rating for the company. Evercore set a $360.00 price objective on Cencora in a research report on Wednesday, April 8th. Robert W. Baird reduced their price objective on shares of Cencora from $420.00 to $339.00 and set an “outperform” rating for the company in a research note on Thursday, May 7th. Citigroup decreased their price target on Cencora from $405.00 to $355.00 and set a “buy” rating on the stock in a research note on Thursday, May 7th. Finally, Morgan Stanley set a $342.00 target price on Cencora in a report on Friday, May 8th. Eleven analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, Cencora has an average rating of “Moderate Buy” and an average price target of $367.75.

Insiders Place Their Bets

In related news, Director Lauren M. Tyler purchased 550 shares of the business’s stock in a transaction dated Monday, June 22nd. The stock was bought at an average cost of $270.23 per share, with a total value of $148,626.50. Following the completion of the acquisition, the director directly owned 4,359 shares in the company, valued at $1,177,932.57. The trade was a 14.44% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.38% of the company’s stock.

Institutional Trading of Cencora

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in COR. Kemnay Advisory Services Inc. acquired a new position in Cencora in the 4th quarter valued at about $25,000. Motiv8 Investments LLC acquired a new stake in shares of Cencora during the 4th quarter worth about $29,000. Turning Point Benefit Group Inc. purchased a new stake in shares of Cencora during the third quarter worth about $74,000. DV Equities LLC purchased a new stake in shares of Cencora during the fourth quarter worth about $91,000. Finally, Greenline Wealth Management LLC acquired a new position in shares of Cencora in the fourth quarter valued at approximately $109,000. Hedge funds and other institutional investors own 97.52% of the company’s stock.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.